Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Nasal Obstruction: early-phase trial registry

3 of 5 indexed Nasal Obstruction trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Nasal Obstruction: 5 US clinical trials tracked, 3 recruiting.

Nasal Obstruction is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lisa Shnayder, running 1 of these trials.

Enrollment posture brief

Registry condition nasal-obstruction

OPEN 3 | RECR 60% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Nasal Obstruction (this)60%
Open-enrollment share among volume-matched conditions near Nasal Obstruction

Nasal Obstruction lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Nasal Obstruction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Nasal Obstruction is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Nasal Obstruction research.

    Lisa Shnayder accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Nasal Obstruction trials plan to enrol fewer than 100 people.

    Median target enrolment is 96 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Nasal Obstruction research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Nasal Obstruction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Vivaer Stylus Device
1 trials
Saline mixture Other
1 trials
Oxymetazoline Nasal Spray Drug
1 trials
Nasal Plug Other
1 trials
Inferior Turbinate Reduction Procedure
1 trials
Septoplasty Procedure
1 trials
Batten batten graft Procedure
1 trials
Budesonide nasal spray Drug
1 trials

US sites by state

Facility locations filed on Nasal Obstruction trials. A trial with sites in several states counts in each.

Missouri 2 trials
Texas 1 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
Louisiana 1 trials
Kansas 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Nasal Obstruction page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Nasal Obstruction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Lisa Shnayder sponsors the most Nasal Obstruction trials on record, review their full trial history before evaluating a specific study. See Lisa Shnayder's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nasal Obstruction condition card totals 5 registered trials; most-linked intervention Vivaer Stylus; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.